• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: UNITED THERAPEUTICS TYVASO INHALATION SYSTEM; NONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

UNITED THERAPEUTICS TYVASO INHALATION SYSTEM; NONE Back to Search Results
Model Number TD-100 / A
Device Problems Thermal Decomposition of Device (1071); Device Emits Odor (1425); Smoking (1585); Battery Problem (2885)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/04/2014
Event Type  malfunction  
Event Description
Base started smoking [device issue].Case description: this case is a spontaneous report from the united states regarding a report received from a consumer via a specialty pharmacy.The patient was a (b)(6), female of unknown height and race who first received tyvaso (treprostinil) on (b)(6) 2013 via inhalation for primary pulmonary hypertension.Inhaled treprostinil dosage was 18-54 micrograms (ug) (3-9 breaths), four times per day (qid) at the time of the event.On (b)(6) 2014, the patient was performing her treatment when the base of the device started smoking.The device then stopped working.No alleged injury.No other information was available.The device was then replaced.The outcome of base started smoking: unknown.Company comments: the company has assessed the serious adverse event of device issue as not related to ih treprostinil.The event was likely related to device malfunction.Reason device not evaluated by mfr: (results pending completion of evaluation).Functional testing of the device was performed.The device displayed "lb" (low battery) error code that could not be cleared and the burning smell / odor was noted.The investigation is in progress at the time of this report.Consumer.Mfr report #: (b)(4).Initial reporter: united states, name and address withheld; consumer.Device manufacture date: 12/2013.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TYVASO INHALATION SYSTEM
Type of Device
NONE
Manufacturer (Section D)
UNITED THERAPEUTICS
MDR Report Key4148264
MDR Text Key4913452
Report NumberMW5038455
Device Sequence Number1
Product Code CAF
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
Report Date 07/04/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/06/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberTD-100 / A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/15/2014
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
TYVASO (TREPROSTINIL SODIUM) INHALATION GAS; 0.6 MG/ML
Patient Outcome(s) Other;
Patient Age66 YR
Patient Weight79
-
-